Share

Networks

Clinical Studies (4)

  • Aguareles : Study aims to investigate the effect of compassionate use of plitidepsin as an antiviral therapy in immunocompromised COVID-19 patients with underlying haematological malignancies or solid tumors, particularly those who have undergone anti-CD20 therapies
  • Leppert : Study aims to evaluate the efficacy and safety of Temelimab as a treatment for post COVID-19 syndrome neuropsychiatric symptoms in patients who had severe acute SARS-CoV-2 infection but did not undergo intensive care treatment during the acute period
  • E-APLICOV-PC : Study aims to evaluate the impact of plitidepsin treatment on reducing viral load and accelerating patient recovery following SARS-CoV-2 infection. To assess whether this treatment could have a relevant impact on the emergence of long-term sequelae resulting from the infection
  • BLOC : Study aims to investigate the efficacy, pharmacodynamics and safety of BC 007 in improving long COVID symptoms by neutralising functional autoantibodies targeting G-protein

Study Data

  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Fragile population
  • Immunocompromised host
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Monoclonal antibodies
  • Plitidepsin
  • BC 007
  • Temelimab

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to